SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-23-049866 from ENZO BIOCHEM INC (ENZ) (CIK 0000316253)

ENZO BIOCHEM INC (ENZ) (CIK 0000316253)
Date: June 20, 2023 · CIK: 0000316253 · Accession: 0001213900-23-049866

AI Filing Summary & Sentiment

File numbers found in text: 333-271911

Date
June 20, 2023
Author
Not clearly detected
Form
CORRESP
Company
ENZO BIOCHEM INC (ENZ) (CIK 0000316253)

Letter

Enzo Biochem, Inc.

81 Executive Blvd., Suite 3

Farmingdale, NY, 11735

June 20, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE: Enzo Biochem, Inc. (CIK 000316253)

Registration Statement No. 333-271911 on Form S-3 (the “Registration Statement”)

Ladies and Gentlemen:

Enzo Biochem, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on June 21, 2023 at 9:30 a.m., Eastern Time, or as soon thereafter as is practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will & Emery LLP, by calling Richard Bass at (212) 547-5476. The Company hereby authorizes Mr. Bass to orally modify or withdraw this request for acceleration.

Very truly yours,
Enzo Biochem, Inc.

Show Raw Text
CORRESP
1
filename1.htm

 Enzo Biochem, Inc.

81 Executive Blvd., Suite 3

Farmingdale, NY, 11735

June 20, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    Enzo Biochem, Inc. (CIK 000316253)

    Registration Statement No. 333-271911 on Form S-3 (the “Registration Statement”)

Ladies and Gentlemen:

Enzo Biochem, Inc. (the “Registrant”)
hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities
Act of 1933, as amended (the “Securities Act”), so that it may become effective on June 21, 2023 at 9:30 a.m., Eastern
Time, or as soon thereafter as is practicable.

The undersigned respectfully requests
that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will & Emery LLP,
by calling Richard Bass at (212) 547-5476. The Company hereby authorizes Mr. Bass to orally modify or withdraw this request for acceleration.

    Very truly yours,

    Enzo Biochem, Inc.

    By:
    /s/ Hamid Erfanian

    Hamid Erfanian

    Chief Executive Officer